Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases

BACKGROUND: Serological severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays differ in the target antigen specificity, e.g. of antibodies directed against the viral spike or the nucleocapsid protein, and in the spectrum of detected immunoglobulins. The aim of the study was to...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Chim Acta
Auteurs principaux: Wolf, Johannes, Kaiser, Thorsten, Pehnke, Sarah, Nickel, Olaf, Lübbert, Christoph, Kalbitz, Sven, Arnold, Benjamin, Ermisch, Jörg, Berger, Luisa, Schroth, Stefanie, Isermann, Berend, Borte, Stephan, Biemann, Ronald
Format: Artigo
Langue:Inglês
Publié: Published by Elsevier B.V. 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7642750/
https://ncbi.nlm.nih.gov/pubmed/33159952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cca.2020.10.035
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires